BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
This highly advanced complex hybrid system features drug-loaded magnetic cationic polymer liposomes (CPL/MCPL). The multi-layered macromolecular architecture features a core reservoir encapsulating a model drug compound alongside superparamagnetic iron oxide nanoparticles, enclosed within a lipid bilayer envelope formulated with a micro-calibrated combination of cationic lipids and surface-bound cationic polymers (such as polyethylenimine). This complex configuration coordinates a robust positive surface potential and high-intensity magnetic resonance tracking handles within a stable polymeric-lipid assembly, altering overall membrane bending elasticity to completely prevent macromolecular dissociation or physical particle aggregation under ambient laboratory testing conditions.
Source
Custom synthesis
Functional Group
Cationic polymer
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.